GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>How about the P2 Atryn results for DIC / sepsis? Is Oct 08 still on for study completion?<

The most recent guidance is for top-line results around the end of 2008 (#msg-24216158, about one-third of the way down). However, GTC has no direct control over the timing of the phase-2 DIC study because is it falls under the auspices of Leo.

I’ll add this item to the news flow post—thanks for mentioning it.